U.S. pharma huge copyright scrapped two experimental weight loss products final 12 months—a at the time-everyday capsule, lotiglipron, as a result of elevated liver enzymes in addition to a 2 times-every day capsule, danuglipron, because of strong Unintended effects—but CEO Albert Bourla has reported the company is decided to “Engage in and g